New vector-control insights to fight malaria in the Asia-Pacific
Official title: Project-002
Funded at Walter and Eliza Hall Inst Medical Res · NIH-11523224 · Data updated 2026-11-12
A multi-institution team in the Asia-Pacific region is testing improved ways to monitor and fight malaria by tracking insecticide resistance and evaluating vector-control tools like nets.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Walter and Eliza Hall Inst Medical Res NIH-funded |
| Lab location | 1 site (Parkville, AUSTRALIA) |
| Project start | April 1, 2025 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $155,518 |
| NIH project number | 3U19AI129392-11S1 |
| Project ID | NIH-11523224 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include communities in malaria-endemic areas of PNG and neighboring countries where vector-control strategies are being deployed.
✕Less likely to help
Communities with little malaria transmission or where surveillance detects no insecticide resistance may see limited direct benefit.
What this research studies
This grant focuses on malaria control in the Asia-Pacific, with a emphasis on Papua New Guinea and neighboring regions. Researchers will develop and test robust vector-surveillance methods to map resistance to insecticides and to understand how current nets perform in real-world settings. The project aims to inform national policies by learning from Cambodia’s elimination experiences and applying those lessons to PNG and other countries in the region. The work combines field data collection, analysis of vector behavior, and evaluation of new transmission-blocking strategies within the context of regional malaria elimination goals.
Why it matters
Potential benefit: If successful, the research could strengthen vector-control programs and accelerate elimination of malaria in the Asia-Pacific.
How similar studies have gone: Previous programs in Cambodia show progress in control measures; this project builds on those experiences to address PNG-specific challenges.
Where this research is happening
-
Walter and Eliza Hall Inst Medical Res
Parkville, Australia Active
Researchers
- Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
- Study coordinator: Mueller, Ivo J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.